Pure Cycle Corp
Change company Symbol lookup
Select an option...
PCYO Pure Cycle Corp
FBBPF Prologis Property Mexico SA de CV
NRZ New Residential Investment Corp
BOMN Boston Omaha Corp
GLD SPDR® Gold Shares
GIS General Mills Inc
GILD Gilead Sciences Inc
GGN GAMCO Global Gold, Natural Resources & Income Trust
GGN GAMCO Global Gold, Natural Resources & Income Trust
GEF Greif Inc
Go

Utilities : Water Utilities | Small Cap Blend
Company profile

Pure Cycle Corporation is an integrated water company that provides wholesale water and wastewater services. The Company provides its services to wholesale customers, which include industrial customers and local governmental entities that provide water and wastewater services to their end-use customers located in the Denver, Colorado metropolitan area. The Company is engaged in selling water service to customers, using water rights owned or controlled by the Company and developing infrastructure to divert, treat and distribute that water and collect, treat and reuse wastewater. The Company owns a portfolio of water rights located in the Denver, Colorado metropolitan area, Southeastern Colorado in the Arkansas River, and the Western Slope of Colorado in the Colorado River. The Company's Denver area assets include Rangeview Water, the Lowry Range Property, Sky Ranch and Arapahoe County Fairgrounds.

Closing Price
$9.79
Day's Change
-0.18 (-1.81%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.07
Day's Low
9.61
Volume
(Light)
Volume:
37,425

10-day average volume:
73,661
37,425

$100+ Billion Biopharmaceutical Logistics Markets - Global Trajectory & Analytics Report 2020 Featuring AmerisourceBergen, DB Schenker, DHL Express, FedEx, United Parcel Service - ResearchAndMarkets.com

9:31 am ET October 2, 2020 (BusinessWire) Print

The "Biopharmaceutical Logistics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Biopharmaceutical Logistics Market to Reach $109.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Biopharmaceutical Logistics estimated at US$78.8 Billion in the year 2020, is projected to reach a revised size of US$109.7 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.

Cold Chain Logistics, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$29.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-cold Chain Logistics segment is readjusted to a revised 4.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $23.2 Billion, While China is Forecast to Grow at 4.5% CAGR

The Biopharmaceutical Logistics market in the U.S. is estimated at US$23.2 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$19.4 Billion by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

AmerisourceBergen Corporation DB Schenker DHL Express Germany GmbH FedEx Corporation United Parcel Service, Inc. (UPS)

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares Biopharmaceutical Logistics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of COVID-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

Market Facts & Figures Biopharmaceutical Logistics Market Share (in %) by Company: 2019 & 2025 Market Analytics Current & Future Analysis for Biopharmaceutical Logistics by Type - Cold Chain Logistics and Non-cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Historic Review for Biopharmaceutical Logistics by Type - Cold Chain Logistics and Non-cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 15-Year Perspective for Biopharmaceutical Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Current & Future Analysis for Biopharmaceutical Logistics by Service - Transportation and Warehousing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Historic Review for Biopharmaceutical Logistics by Service - Transportation and Warehousing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 15-Year Perspective for Biopharmaceutical Logistics by Service - Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027

IV. COMPETITION

Total Companies Profiled: 41

For more information about this report visit https://www.researchandmarkets.com/r/3y48qs

View source version on businesswire.com: https://www.businesswire.com/news/home/20201002005296/en/

SOURCE: Research and Markets

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com 
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.